Page last updated: 2024-11-08

biguanides and Cancer of Pituitary

biguanides has been researched along with Cancer of Pituitary in 1 studies

Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vázquez-Borrego, MC1
Fuentes-Fayos, AC1
Herrera-Martínez, AD1
L-López, F1
Ibáñez-Costa, A1
Moreno-Moreno, P1
Alhambra-Expósito, MR1
Barrera-Martín, A1
Blanco-Acevedo, C1
Dios, E1
Venegas-Moreno, E1
Solivera, J1
Gahete, MD1
Soto-Moreno, A1
Gálvez-Moreno, MA1
Castaño, JP1
Luque, RM1

Other Studies

1 other study available for biguanides and Cancer of Pituitary

ArticleYear
Biguanides Exert Antitumoral Actions in Pituitary Tumor Cells Through AMPK-Dependent and -Independent Mechanisms.
    The Journal of clinical endocrinology and metabolism, 2019, 08-01, Volume: 104, Issue:8

    Topics: AMP-Activated Protein Kinases; Antineoplastic Agents; Apoptosis; Biguanides; Cell Line, Tumor; Cell

2019